| Melphalan studied in …STUDIED_INderived200 of 578show all (up to 200) |
|---|
| → studied in | NCT06377540Phase 2 · recruiting MT2022-60: Ph 2 Study of Pembro+ BEAM With ASCT for Relapsed Hodgkin Lymphoma · 578 trials list this drug (82 active) | — | — | Classic Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07605416Phase 2 · recruiting Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial · 578 trials list this drug (82 active) | — | — | Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03494569Phase 1 · suspended Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic Syndrome · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564390Phase 2 · recruiting MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) · 578 trials list this drug (82 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic/Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172296Phase 3 · recruiting Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma · 578 trials list this drug (82 active) | — | — | Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01857934Phase 2 · completed Therapy for Children With Advanced Stage Neuroblastoma · 578 trials list this drug (82 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03004287Phase 2 · active not recruiting 2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03849651Phase 2 · active not recruiting TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01279694Phase 1/Phase 2 · completed Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP) · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05436418Phase 1/Phase 2 · recruiting The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05903937Phase 1 · not yet recruiting Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases · 578 trials list this drug (82 active) | — | — | Cutaneous Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06954987Phase 2 · not yet recruiting Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) · 578 trials list this drug (82 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07183852Phase 1 · not yet recruiting Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma · 578 trials list this drug (82 active) | — | — | Cutaneous Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07624513Phase 3 · not yet recruiting D2 - Isa-Iber-VD Induction, Followed by Risk & Response Adapted Consolidation & Maintenance, in Transplant-Eligible NDMM · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07025824Phase 2 · recruiting Evaluation of Treosulfan Versus Melphalan Conditioning Followed by PTCy in Patients With AML and MDS Undergoing Allogeneic Transplantation · 578 trials list this drug (82 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06523699Phase 1 · active not recruiting Impact of Recombinant Human Interleukin-7 (CYT107) on Tumor Clearance and Immune Reconstitution in Multiple Myeloma Patients After Autologous Hematopoietic Cell Transplant · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602641Phase 3 · active not recruiting Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07257419Phase 1 · recruiting CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for Relapsed/Refractory CD19+ ALL and Lymphoma · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Childhood Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01885689Phase 2 · active not recruiting Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia · 578 trials list this drug (82 active) | — | — | Myelodysplastic Syndrome,Secondary Myelodysplastic Syndrome,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00114101Phase 3 · active not recruiting Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Multiple Myeloma,Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126916Phase 3 · recruiting Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL) · 578 trials list this drug (82 active) | — | — | Ganglioneuroblastoma,Neuroblastoma,Ganglioneuroblastoma, Nodular | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05504291Phase 2 · recruiting A Study to Give Treatment Inside the Eye to Treat Retinoblastoma · 578 trials list this drug (82 active) | — | — | Retinoblastoma,Childhood Intraocular Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06158828Phase 1/Phase 2 · recruiting Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML · 578 trials list this drug (82 active) | — | — | Acute Myeloid Leukemia,Childhood Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07582172Phase 2 · recruiting Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome · 578 trials list this drug (82 active) | — | — | Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia,Acute Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01810588Phase 2 · completed Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07228624Phase 2 · recruiting Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes · 578 trials list this drug (82 active) | — | — | Myelodysplastic/Myeloproliferative Neoplasm,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06001385Phase 2 · active not recruiting HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis · 578 trials list this drug (82 active) | — | — | Lymphoma,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06207799Phase 2 · recruiting Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03346135Phase 2 · active not recruiting Daratumumab After Stem Cell Transplant in Treating Patients With Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02443077Phase 3 · active not recruiting Ibrutinib Before and After Stem Cell Transplant in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma · 578 trials list this drug (82 active) | — | — | Diffuse Large B-Cell Lymphoma Activated B-Cell Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06287944Phase 1 · recruiting 225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02727803Phase 2 · recruiting Personalized NK Cell Therapy in CBT · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03259503Phase 1 · completed Olaparib and High-Dose Chemotherapy in Treating Patients With Relapsed or Refractory Lymphomas Undergoing Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Hodgkin Lymphoma,T-Cell Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05457556Phase 3 · active not recruiting Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735637Phase 3 · not yet recruiting A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6). · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04022239Phase 1/Phase 2 · recruiting Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphatic System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05139004Phase 1 · active not recruiting 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Secondary Acute Myeloid Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996119Phase 1 · recruiting Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant · 578 trials list this drug (82 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04098393Phase 1 · active not recruiting Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06815003Phase 2 · recruiting Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Myeloproliferative Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662018recruiting Prospective Observational Study of Outcomes After Gemcitabine, Docetaxel, Melphalan, and Carboplatin With Autologous Stem Cell Transplantation in Pediatric Relapsed/Refractory Germ Cell Tumors · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04483206Phase 1 · recruiting Personalized Autologous Transplant for Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04994977Phase 1 · terminated Intra-Arterial Chemotherapy for Newly Diagnosed, Residual, or Recurrent Atypical Choroid Plexus Papilloma and Choroid Plexus Carcinoma Prior to Second-Look Surgery · 578 trials list this drug (82 active) | — | — | Atypical Choroid Plexus Papilloma,Choroid Plexus Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01702831Phase 2 · completed Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544115Phase 2 · active not recruiting Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders · 578 trials list this drug (82 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03786783Phase 2 · completed Dinutuximab, Sargramostim, and Combination Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma · 578 trials list this drug (82 active) | — | — | Ganglioneuroblastoma,High Risk Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07052370Phase 1 · recruiting TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01840566Phase 1 · active not recruiting High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma · 578 trials list this drug (82 active) | — | — | Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00869232Phase 2 · active not recruiting UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02797470Phase 1/Phase 2 · active not recruiting Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Adult Hodgkin Lymphoma,Adult Non-Hodgkin Lymphoma,Burkitt Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05088356Phase 1 · active not recruiting Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Leukemia,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00871013Phase 2 · active not recruiting Trial for Patients Not Qualifying for TT4 and TT5 Protocols Because of Prior Therapy · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04872595Phase 2 · active not recruiting A Modified Dose of Rabbit Anti-thymocyte Globulin (rATG) in Children and Adults Receiving Treatment to Help Prepare Their Bodies for a Bone Marrow Transplant · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06022939Phase 3 · recruiting Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis · 578 trials list this drug (82 active) | — | — | AL Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03821610Phase 2 · active not recruiting A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC) · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06195891Phase 1 · recruiting Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Myelodysplastic Syndrome,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00253435Phase 2 · completed N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma · 578 trials list this drug (82 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06679829Phase 2 · recruiting A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03856216Phase 2 · terminated Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation · 578 trials list this drug (82 active) | — | — | Lymphocytic Neoplasm,Lymphoma,Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03192397Phase 1/Phase 2 · active not recruiting Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Hodgkin Lymphoma,Multiple Myeloma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01054196Phase 1/Phase 2 · active not recruiting Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05735717Phase 2 · recruiting MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06692452Phase 2 · withdrawn Tazemetostat Plus CHOP in 1L T-cell Lymphoma · 578 trials list this drug (82 active) | — | — | Lymphoma,Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type,Peripheral T-Cell Lymphoma, Not Otherwise Specified+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02333162Phase 1 · suspended Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Myelodysplastic Syndrome,Adult Acute Lymphoblastic Leukemia+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04339101Phase 2 · completed Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation · 578 trials list this drug (82 active) | — | — | Acute Leukemia,Myelodysplastic Syndrome,Primary Myelofibrosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01453088Phase 2 · terminated Auto Transplant High Dose Melphalan vs High Dose Melphalan+Bortezomib in Pts With Multiple Myeloma Age 65 Years or Older · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04904588Phase 2 · active not recruiting HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide · 578 trials list this drug (82 active) | — | — | Lymphoma,Acute Leukemia,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01804634Phase 2 · recruiting Reduced Intensity Haploidentical BMT for High Risk Solid Tumors · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05565105Phase 2 · not yet recruiting CD34+ Transplants for Leukemia and Lymphoma · 578 trials list this drug (82 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00716066Phase 2 · active not recruiting Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003042Phase 2 · completed Chemotherapy and Stem Cell Transplantation in Treating Patients With Stage IIIB Breast Cancer · 578 trials list this drug (82 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00544466Phase 1/Phase 2 · active not recruiting Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies · 578 trials list this drug (82 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01625351Phase 1 · completed A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas · 578 trials list this drug (82 active) | — | — | Digestive System Neoplasm,Germ Cell Tumor,Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06028828Phase 2 · recruiting Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04150042Phase 1 · recruiting SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells · 578 trials list this drug (82 active) | — | — | Malignant Breast Neoplasm,Malignant Pancreatic Neoplasm,Breast Adenocarcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03159702Phase 2 · completed Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01175356Phase 1 · completed Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin · 578 trials list this drug (82 active) | — | — | Ganglioneuroblastoma,Neuroblastoma,Regional Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02896582Phase 2 · completed Efficacy of Upfront and Maintenance Obinutuzumab in Mantle Cell Lymphoma Treated by DHAP and MRD Driven Maintenance · 578 trials list this drug (82 active) | — | — | Mantle Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03674411Phase 2 · active not recruiting Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04395222Phase 2 · active not recruiting Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05115630Phase 2 · completed Off-the-shelf NK Cells + SCT for Myeloid Malignancies · 578 trials list this drug (82 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Chronic Myeloid Leukemia, BCR-ABL1 Positive | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04191187Phase 2 · completed Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03352765Phase 1 · active not recruiting A Phase I Study of Bendamustine and Melphalan Conditioning and Autologous Stem Cell Transplantation for Treatment of Multiple Myeloma and Relapsed/Refractory B-cell Lymphoma in Elderly Patients · 578 trials list this drug (82 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03342196Phase 2 · completed Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation · 578 trials list this drug (82 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03829371Phase 4 · active not recruiting STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02866136Phase 2 · active not recruiting Conservative Treatments of Retinoblastoma · 578 trials list this drug (82 active) | — | — | Retinal Neoplasm,Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01526096Phase 1 · completed Stem Cell Transplantation for Patients With Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03125642Phase 2 · recruiting Auto Stem Cell Transplant for Lymphoma Patients · 578 trials list this drug (82 active) | — | — | Hodgkin Lymphoma,Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05031897Phase 2 · recruiting Two Step Haplo With Radiation Conditioning · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphatic System Neoplasm,Myeloid Neoplasm,Acute Lymphoblastic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02605421Phase 2 · recruiting Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma · 578 trials list this drug (82 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03602235Phase 1 · completed High Dose Ascorbic Acid for Plasma Cell Disorders · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04678401Phase 1 · recruiting IS-free Treg HaploHCT · 578 trials list this drug (82 active) | — | — | Myelodysplastic Syndrome,Myeloid Leukemia,Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03016806recruiting Umbilical Cord Blood Transplantation From Unrelated Donors · 578 trials list this drug (82 active) | — | — | Solid Neoplasm,Lymphoma,Acute Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04812470Phase 1 · completed Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases · 578 trials list this drug (82 active) | — | — | Cutaneous Melanoma,Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05893654Phase 1/Phase 2 · enrolling by invitation Melphalan Chemoreduction for Ocular Melanoma · 578 trials list this drug (82 active) | — | — | Uveal Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00357565Phase 2 · completed Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia · 578 trials list this drug (82 active) | — | — | Leukemia,Childhood Myelodysplastic Syndrome,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02195479Phase 3 · completed A Study of Combination of Daratumumab and Velcade (Bortezomib) Melphalan-Prednisone (DVMP) Compared to Velcade Melphalan-Prednisone (VMP) in Participants With Previously Untreated Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02790515Phase 2 · active not recruiting Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation · 578 trials list this drug (82 active) | — | — | Myeloid Sarcoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04473911Phase 1 · completed Haplo Peripheral Blood Sct In GVHD Prevention · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04530487Phase 2 · terminated Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults · 578 trials list this drug (82 active) | — | — | Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,Malignant Solid Neoplasm,Malignant Peripheral Nerve Sheath Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00112827Phase 1/Phase 2 · completed Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma,Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01350258Phase 1/Phase 2 · terminated Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03583424Phase 1/Phase 2 · completed Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma · 578 trials list this drug (82 active) | — | — | Non-Hodgkin Lymphoma,Diffuse Large B-Cell Lymphoma,Follicular Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04690192Phase 1/Phase 2 · completed CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04342572Phase 1 · completed Intra-arterial Chemotherapy for Retinoblastoma · 578 trials list this drug (82 active) | — | — | Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01729091Phase 2 · completed Umbilical Cord Blood-Derived Natural Killer Cells, Elotuzumab, Lenalidomide, and High Dose Melphalan, Followed by Stem Cell Transplant in Treating Patients With Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma,Plasma Cell Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03417284Phase 1/Phase 2 · completed Melphalan Hydrochloride in Treating Participants With Newly-Diagnosed Multiple Myeloma Undergoing Donor Stem Cell Transplantation · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412565Phase 2 · completed A Study to Evaluate Subcutaneous Daratumumab in Combination With Standard Multiple Myeloma Treatment Regimens · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01998971Phase 1 · completed A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06140966Phase 2 · recruiting Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03615105Phase 2 · terminated Donor Stem Cell Transplantation Using α/β+ T-lymphocyte Depleted Grafts From HLA Mismatched Donors · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Non-Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01085617completed Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia · 578 trials list this drug (82 active) | — | — | Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00638898Phase 1 · completed Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor · 578 trials list this drug (82 active) | — | — | Solid Neoplasm,Adult Solid Neoplasm,Childhood Solid Neoplasm+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01476839Phase 1 · completed Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma · 578 trials list this drug (82 active) | — | — | Adult Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01758328Phase 1 · completed Dose Escalation Trial of WT1-specific Donor-derived T Cells Following T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed/Refractory Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02342782Phase 1 · completed Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma · 578 trials list this drug (82 active) | — | — | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma,Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506959Phase 2 · completed Panobinostat, Gemcitabine Hydrochloride, Busulfan, and Melphalan Before Stem Cell Transplant in Treating Patients With Refractory or Relapsed Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma,Plasma Cell Leukemia,Plasmacytoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04903678NA · recruiting Intrathecal Chemotherapy for Central Nervous System Metastasis in Retinoblastoma · 578 trials list this drug (82 active) | — | — | Extraocular Retinoblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06829472Phase 3 · recruiting Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03187223Phase 2 · completed Bendamustine and Melphalan in Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02880293NA · completed Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002730Phase 1 · completed Chemotherapy in Treating Children With Neuroblastoma · 578 trials list this drug (82 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02043847Phase 1 · completed TMI With HD Mel in ASCT for R/R Multiple Myeloma (BMT-03) · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01091831Phase 3 · completed Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04521946Phase 1 · withdrawn Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer · 578 trials list this drug (82 active) | — | — | Primitive Neuroectodermal Tumor,Anaplastic Ependymoma,Atypical Teratoid/Rhabdoid Tumor+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04982354Phase 1/Phase 2 · withdrawn Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia · 578 trials list this drug (82 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06613035Phase 3 · not yet recruiting Twice-per-weekSelinexor, 2 Days Melphalan · 578 trials list this drug (82 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03691376Phase 1 · terminated Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · 578 trials list this drug (82 active) | — | — | Primary Peritoneal Carcinoma,Ovarian Carcinoma,Platinum-Resistant Primary Peritoneal Carcinoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00936936Phase 2 · completed High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors · 578 trials list this drug (82 active) | — | — | Malignant Testicular Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00551928Phase 3 · completed Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01798004Phase 1 · completed Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma · 578 trials list this drug (82 active) | — | — | Ganglioneuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02295722Phase 1/Phase 2 · terminated GEMHDM2014 : Gem-HDM HDT and ASCT for Relapsed/ Refractory Lymphoma · 578 trials list this drug (82 active) | — | — | Follicular Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05636787Phase 2 · recruiting Clinical Trial Investigating the Chemotherapeutic Compound Treosulfan (Trecondi® Ideogen) in Myeloma Patients · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00547196NA · completed AlloHCT From Matched Unrelated Donors in Pts w/ Advanced Hematologic Malignancies & Disorders · 578 trials list this drug (82 active) | — | — | Leukemia,Lymphoma,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02061800Phase 1/Phase 2 · unknown CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Lymphoma,Acute Lymphoblastic Leukemia,Juvenile Myelomonocytic Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06425276Phase 4 · completed Evaluate Safety and Efficacy of High-dose Melphalan HCL for Injection in MM Patients With Auto-HSC Transplantation · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03188172Phase 2 · unknown MUK Nine b: OPTIMUM Treatment Protocol · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02728102Phase 2 · completed Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401) · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03292263Phase 1/Phase 2 · unknown ASCT With Nivolumab in Patients With Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03217812Phase 3 · completed A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region) · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05013437early Phase 1 · withdrawn Melphalan on Disease Burden Measured by Next Generation Sequencing Before AHCT (Autologous Hematopoietic Cell Transplant) for Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02700841Phase 2 · terminated Enhancing Anti--Tetanus Vaccine Response After Autologous Stem Cell Transplantation · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019097Phase 2 · completed Vaccine Therapy in Treating Patients With Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma,Plasma Cell Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01505569NA · completed Auto Transplant for High Risk or Relapsed Solid or CNS Tumors · 578 trials list this drug (82 active) | — | — | Germ Cell Tumor,Central Nervous System Neoplasm,Hepatoblastoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01526603NA · completed High Dose Chemotherapy and Autologous Transplant for Neuroblastoma · 578 trials list this drug (82 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00577278Phase 2 · completed A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan · 578 trials list this drug (82 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04466475Phase 1 · withdrawn Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01904136Phase 1/Phase 2 · completed Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia · 578 trials list this drug (82 active) | — | — | Myelodysplastic Syndrome,Acute Myeloid Leukemia,Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03128359Phase 2 · completed High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Acute Leukemia,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00520767Phase 2 · completed Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease · 578 trials list this drug (82 active) | — | — | Light Chain Deposition Disease,Primary Systemic Amyloidosis | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00968760Phase 1 · completed CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies · 578 trials list this drug (82 active) | — | — | B-Cell Malignant Neoplasm,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04682405Phase 2 · completed Uproleselan (GMI-1271) for GI Toxicity Prophylaxis During Melphalan-Conditioned Autologous Hematopoietic Cell Transplantation (Auto-HCT) for Multiple Myeloma (MM) · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03072771Phase 1 · completed Blinatumomab Consolidation Post Autologous Stem Cell Transplantation in Patients With Diffuse Large B-Cell Lymphoma (DLBCL) · 578 trials list this drug (82 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00734149Phase 2 · completed Bortezomib With Melphalan and Prednisone for Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019760Phase 2 · completed Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the Liver · 578 trials list this drug (82 active) | — | — | Malignant Colon Neoplasm,Malignant Rectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019968Phase 2 · completed Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or Leg · 578 trials list this drug (82 active) | — | — | Adult Soft Tissue Sarcoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02206425Phase 1/Phase 2 · completed Ixazomib as a Replacement for Carfilzomib and Bortezomib for Multiple Myeloma Patients · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03096782Phase 2 · completed Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma · 578 trials list this drug (82 active) | — | — | Acute Leukemia,Acute Lymphoblastic Leukemia,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01035463Phase 1/Phase 2 · completed Lenalidomide Therapy After Chemotherapy & Stem Cell Transplant in Treating Chemotherapy Resistan Non-Hodgkin Lymphoma · 578 trials list this drug (82 active) | — | — | Anaplastic Large Cell Lymphoma,Non-Hodgkin Lymphoma,Anaplastic Large Cell Lymphoma, ALK-Negative+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00080886Phase 2 · completed Rituximab, Carmustine; Cytarabine, Etoposide, & Melphalan; Stem Cell Transplantation for Non-Hodgkin's Lymphoma · 578 trials list this drug (82 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04455139Phase 2 · terminated A Prospective International Multicenter Clinical Trial for Eyes With Relapsed Retinoblastoma · 578 trials list this drug (82 active) | — | — | Malignant Eye Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00574496Phase 2 · completed Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma · 578 trials list this drug (82 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02771197Phase 2 · completed Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant · 578 trials list this drug (82 active) | — | — | Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04205240Phase 2 · terminated Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006695Phase 2 · completed Monoclonal Antibody Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplant in Non-Hodgkin's Lymphoma · 578 trials list this drug (82 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00007852Phase 2 · completed Rituximab & Combination Chemotherapy Followed by Transplantation in Relapsed or Refractory Non-Hodgkin's Lymphoma · 578 trials list this drug (82 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00305812Phase 2 · completed Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003353Phase 2 · completed High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00014508Phase 2 · completed Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00052884Phase 1 · terminated Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00641030Phase 1 · completed Clofarabine and High-Dose Melphalan Followed by Donor Stem Cell Transplant in Patients With Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Myelodysplastic Syndromes · 578 trials list this drug (82 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03073694Phase 2 · unknown Comparing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis · 578 trials list this drug (82 active) | — | — | Malignant Appendix Neoplasm,Malignant Colorectal Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00074269Phase 2 · terminated Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer · 578 trials list this drug (82 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00566098Phase 1/Phase 2 · completed Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05863845NA · unknown Efficacy and Safety of Venetoclax Combined With BEAM Pretreatment in Autologous Transplantation for DLBCL · 578 trials list this drug (82 active) | — | — | Diffuse Large B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02581007Phase 2 · completed Reduced Intensity Conditioning Transplant Using Haploidentical Donors · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01907009Phase 2/Phase 3 · terminated A Phase II Study Evaluating Intravenous Melphalan With Autologous Whole Blood Stem Cell Transplantation Over Three Cycles In Patients With Castration-Resistant Prostate Cancer (MEL-CAP) · 578 trials list this drug (82 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05438394Phase 1 · unknown Clinical Study of Safety and Tolerability of Melphalan Hydrochloride for R/R MM · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005835Phase 1 · completed N99-02: Melphalan and Buthionine Sulfoximine · 578 trials list this drug (82 active) | — | — | Neuroblastoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01256398Phase 2 · completed Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Adult B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02960646Phase 1 · completed Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,Hodgkin Lymphoma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03019640Phase 2 · completed Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma · 578 trials list this drug (82 active) | — | — | Diffuse Large B-Cell Lymphoma,Follicular Lymphoma,Indolent Adult Non-Hodgkin Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01746173Phase 2 · terminated CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma · 578 trials list this drug (82 active) | — | — | T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05228249Phase 1 · withdrawn Loncastuximab Tesirine in Combination With Chemotherapy Prior to Stem Cell Transplant for the Treatment of Recurrent or Refractory Diffuse Large B-Cell Lymphoma · 578 trials list this drug (82 active) | — | — | Diffuse Large B-Cell Lymphoma,Primary Mediastinal Large B-Cell Lymphoma,Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00995059Phase 1/Phase 2 · withdrawn Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01141712Phase 2 · completed Autologous Transplant in HIV Patients (BMT CTN 0803) · 578 trials list this drug (82 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02440464Phase 2 · completed Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302) · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00423514Phase 1/Phase 2 · completed Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease · 578 trials list this drug (82 active) | — | — | Leukemia,Myelodysplastic Syndrome | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03393611Phase 1 · completed CPX-351 Salvage Therapy Followed by Haplo-Cord Transplant for Relapsed/Refractory Leukemia or Myelodysplastic Syndrome · 578 trials list this drug (82 active) | — | — | Leukemia,Myelodysplastic Syndrome,Adult Acute Myeloid Leukemia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02780609Phase 1/Phase 2 · completed Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807611Phase 2 · completed Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy · 578 trials list this drug (82 active) | — | — | Leukemia,Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02415036Phase 2 · terminated Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma · 578 trials list this drug (82 active) | — | — | Hepatocellular Carcinoma,Intrahepatic Cholangiocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02716805Phase 1 · terminated Phase 1 Study of Tremelimumab, Durvalumab, High-dose Chemotherapy, + Autologous Stem Cell Transplant · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03852407Phase 2 · recruiting Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Hodgkin Lymphoma,Multiple Myeloma+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04282174Phase 2 · withdrawn CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies · 578 trials list this drug (82 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Acute Lymphoblastic Leukemia,Myeloid Leukemia+2 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03742297Phase 3 · active not recruiting Treatment for Elderly Fit Newly Diagnosed Multiple Myeloma Patients Aged Between 65 and 80 Years · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02415413Phase 2 · active not recruiting Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Smoldering Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00784823Phase 1/Phase 2 · completed Study Combining Bortezomib With High Dose Melphalan to Treat Multiple Myeloma · 578 trials list this drug (82 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01119066Phase 2 · completed HLA-Compatible Related or Unrelated Donors With CD34+ Enriched, T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System in the Treatment of Patients With Hematologic Malignancies · 578 trials list this drug (82 active) | — | — | Acute Lymphoblastic Leukemia,Multiple Myeloma,Myelodysplastic Syndrome+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05466318Phase 3 · unknown ChiCGB vs BEAM in High-risk or R/R Lymphomas · 578 trials list this drug (82 active) | — | — | Lymphoma,T-Cell Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |